Thrivent Financial For Lutherans Biomarin Pharmaceutical Inc Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 45,073 shares of BMRN stock, worth $3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

45,073

Previous 46,225 2.49%

Holding current value

$3 Million

Previous $3.81 Million 16.76%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$69.02 - $93.84 $79,511 - $108,103	-1,152 Reduced 2.49%	45,073 $3.17 Million
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $3.44 Million - $4.26 Million	46,225 New	46,225 $3.81 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $59,635 - $69,006	-688 Reduced 22.33%	2,393 $207,000
Q1 2023 May 17, 2023	BUY	$87.74 - $117.27 $270,326 - $361,308	3,081 New	3,081 $300,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $1.93 Million - $2.35 Million	-25,884 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $139,774 - $173,635	1,925 Added 8.03%	25,884 $2.27 Million
Q3 2020 Nov 10, 2020	SELL	$71.87 - $131.03 $220,497 - $402,000	-3,068 Reduced 11.35%	23,959 $1.82 Million
Q2 2020 Aug 12, 2020	SELL	$79.55 - $124.22 $8.84 Million - $13.8 Million	-111,067 Reduced 80.43%	27,027 $3.33 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $2.13 Million - $2.89 Million	-29,847 Reduced 17.77%	138,094 $11.7 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $1.62 Million - $2.17 Million	25,174 Added 17.63%	167,941 $14.2 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $24,803 - $31,320	368 Added 0.26%	142,767 $9.62 Million
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $64.7 Million - $75.6 Million	-805,278 Reduced 84.97%	142,399 $12.2 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $1.5 Million - $1.76 Million	-17,858 Reduced 1.85%	947,677 $84.2 Million
Q4 2018 Feb 15, 2019	BUY	$80.14 - $106.07 $51.3 Million - $67.8 Million	639,531 Added 196.17%	965,535 $82.2 Million
Q3 2018 Nov 15, 2018	SELL	$93.92 - $105.72 $856,550 - $964,166	-9,120 Reduced 2.72%	326,004 $31.6 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $67.6 Million - $88.1 Million	-889,652 Reduced 72.64%	335,124 $31.6 Million
Q1 2018 May 08, 2018	BUY	$77.67 - $92.63 $81.2 Million - $96.8 Million	1,044,921 Added 580.98%	1,224,776 $99.3 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $722,802 - $851,413	8,950 Added 5.24%	179,855 $16 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $13.8 Million - $16.2 Million	170,905	170,905 $15.9 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Biomarin Pharmaceutical Inc Transaction History